National Bureau of Statistics: Compared with the end of November, the market prices of 50 kinds of important means of production in 9 categories in the national circulation field increased in early December, 23 kinds decreased and 4 kinds remained flat. The National Bureau of Statistics released the market price changes of important means of production in the circulation field in early December 2024: According to the monitoring of the market prices of 50 kinds of important means of production in 9 categories in the national circulation field, compared with the end of November, the prices of 23 kinds of products increased in early December 2024, 23.Wafer factory "bargains for orders"? Insiders: It's not so exaggerated that there is no need for drastic price reduction at present. Recently, some industry media reported that the Chinese mainland wafer foundry has overflowed its capacity and is striving for more IC design factory orders to return at a low price discount. A manager of Chinese mainland Head Wafer Factory told reporters that the actual situation was "not as serious as reported by the media, and not so exaggerated". The source said that since the fourth quarter of this year, the quotation of its wafer factory has been "stable at present". In the fourth quarter, product orders from display drivers, power management and other categories were "not bad", and the market demand was similar to that previously publicly disclosed. The independent control of the mainland market is still the main theme. It is understood that the fourth quarter is usually the "off-season" of the wafer foundry industry, and downstream customers will review the sales plan at the beginning of the year, and they are not willing to stock up and receive goods. A person from a consumer chip company in Chinese mainland said, "Fab factories generally adjust prices according to market supply and demand." Yang Shengxin, a senior analyst of Sigmaintell's semiconductor business unit, said in an interview that according to the observation of Sigma Intell, Chinese mainland's wafer factory decreased by about 5% in the fourth quarter of 2024, and concentrated on 12-inch products; The price of China Taiwan Province Wafer Factory has not changed significantly. (science and technology innovation board Daily)When meeting with Bona, the foreign affairs adviser to the French President, He Lifeng pointed out that the stable and healthy development of economic and trade relations should be promoted through high-level openness to achieve mutual benefit and win-win. He Lifeng, member of the Political Bureau of the Communist Party of China (CPC) Central Committee and Vice Premier of the State Council, met Bona, the foreign affairs adviser to the French President, at the Great Hall of the People on the evening of 13th. He Lifeng said that China has always regarded France as a priority partner in its development. China is willing to work with France to implement the consensus of the two heads of state, strengthen strategic dialogue, deepen cooperation in traditional fields, expand cooperation in emerging fields, promote the stable and healthy development of China-France and China-EU economic and trade relations with a high level of openness, better cope with common challenges, and achieve mutual benefit and win-win results. Bona said that France supports promoting open cooperation through constructive dialogue and is willing to work with China to promote the sustained, balanced and high-quality development of economic and trade cooperation between the two countries. (Xinhua News Agency)
Challenging the monopoly of Europe and America, Chinese and Indian manufacturers have laid out the track of diet pills. For some time, GLP-1 (glucagon-like peptide -1) diet pills have caught fire in the United States and other western countries, and gradually marched into emerging markets. At present, two major pharmaceutical companies, Novo Nordisk in Denmark and Lilly in the United States, occupy most of the market share in the field of GLP-1 diet pills, but other pharmaceutical companies are also actively deploying the track. In 2026, Novo Nordisk's patent on smeagoutide will expire in China and India, while the patent on liraglutide, the main effective ingredient of the previous generation of GLP-1 diet pills, has expired in China and India. The industry believes that China and India, as two emerging markets, have a strong momentum of innovation and development in the pharmaceutical industry of both countries, and have great potential in the GLP-1 diet pills track. The entry of Chinese and Indian pharmaceutical companies will make the international competition in the field of GLP-1 diet pills more intense. (Global Times)Report: The number of online stores opened by China enterprises in the United States has increased rapidly. According to the report released by SmartScout Insight, among the top 20 cities in terms of Amazon sellers, China city occupies 14 seats, showing the strong strength of China sellers on Amazon platform. The total number of Amazon sellers in China's top 20 cities reached 232,000, compared with 58,000 in the United States. In 2023, the number of sellers in China with sales exceeding $10 million increased by 30% year-on-year, and the number of sellers in China with sales exceeding $1 million also increased significantly.China Construction Group signed a strategic cooperation agreement with Wuhan University. On December 13th, Wen Bing, deputy party secretary and general manager of China Construction Group, held talks with Zhang Pingwen, president of Wuhan University and academician of China Academy of Sciences, and China Construction Group signed a strategic cooperation agreement with Wuhan University. According to the cooperation agreement, the two sides will give full play to their respective advantages, establish a long-term mechanism and deepen all-round cooperation in the fields of industrial incubation, talent cultivation, scientific research transformation and engineering construction.
Shanghai Airlines Exchange: This week, the export container transportation market was basically stable, and the market freight rates fluctuated. According to Shanghai Airlines Exchange, this week, the export container transportation market in China was basically stable, and different routes were divided due to their different supply and demand fundamentals, and the comprehensive index rose. On December 13th, the comprehensive freight index of Shanghai export containers released by Shanghai Shipping Exchange was 2,384.40 points, up 5.7% from the previous period.Challenging the monopoly of Europe and America, Chinese and Indian manufacturers have laid out the track of diet pills. For some time, GLP-1 (glucagon-like peptide -1) diet pills have caught fire in the United States and other western countries, and gradually marched into emerging markets. At present, two major pharmaceutical companies, Novo Nordisk in Denmark and Lilly in the United States, occupy most of the market share in the field of GLP-1 diet pills, but other pharmaceutical companies are also actively deploying the track. In 2026, Novo Nordisk's patent on smeagoutide will expire in China and India, while the patent on liraglutide, the main effective ingredient of the previous generation of GLP-1 diet pills, has expired in China and India. The industry believes that China and India, as two emerging markets, have a strong momentum of innovation and development in the pharmaceutical industry of both countries, and have great potential in the GLP-1 diet pills track. The entry of Chinese and Indian pharmaceutical companies will make the international competition in the field of GLP-1 diet pills more intense. (Global Times)Meta stepped in to discourage OpenAI from turning into a profit-making enterprise, and Meta urged the Attorney General of California to stop OpenAI from turning into a profit-making enterprise. Meta said that allowing OpenAI to become a for-profit company will set a dangerous precedent, that is, allowing startups to enjoy the advantage of non-profit status before preparing for profit.
Strategy guide 12-14
Strategy guide 12-14